Dewpoint Therapeutics, Inc.
New Filing
CIK: 0001828893·Biotechnology·DELAWARE·Filed: Feb 4, 2022
Total Offering
$149,999,989
Amount Sold
$149,999,989
Investors
18
First Sale
Jan 26, 2022
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2018
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Amir H. Nashat | Related Person |
| Srinivas Akkaraju, M.D., Ph.D. | Related Person |
| Olivier Brandicourt, M.D. | Related Person |
| Giuseppe Ciaramella, Ph.D. | Related Person |
| Anthony A. Hyman, Ph.D. | Related Person |
| Juergen Eckhardt, M.D. | Related Person |
| Mark Murcko, Ph.D. | Related Person |
| Ameet Nathwani, M.D. | Related Person |
| Richard A. Young, Ph.D. | Related Person |
| Regina Barzilay, Ph.D. | Related Person |
| Joel D. Sendek | Related Person |
| Isaac A. Klein, M.D., Ph.D. | Related Person |
| Lori Escobedo | Related Person |
Company
SEC Filing
0001567619-22-002514
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free